STOCK TITAN

2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
2seventy bio, Inc. (TSVT) to announce Q4 and full year 2023 financial results on March 5, 2024. Management team to present at investor conferences. Earnings call scheduled for March 5, 2024, at 8:00 a.m. ET. Webcasts available for investor conference presentations and earnings call.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- 2seventy bio, Inc. (Nasdaq: TSVT) will announce its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024. A conference call and webcast will be held at 8:00 a.m. ET.

Members of the management team will also be presenting at the following upcoming investor conferences:

  • TD Cowen 44th Annual Healthcare Conference in Boston, MA on Wednesday, March 6, 2024 at 2:10 p.m. ET
  • Leerink Partners Global Biopharma Conference in Miami, FL on Wednesday, March 13 at 8:00 a.m. ET

Live webcasts of the investor conference presentations will be available via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/. Replays will be archived on 2seventy bio’s site for 30 days following the event.

Earnings Call Information

2seventy bio will host a conference call and live webcast on March 5, at 8:00 a.m. ET to discuss fourth quarter 2023 / full year 2023 financial results and recent business highlights. To join the live conference call, please register at: https://register.vevent.com/register/BI1f96356c45184868a0cde91b2864ffd8. Upon registering, each participant will be provided with call details and access codes. The live webcast may be accessed by visiting the event link at: https://edge.media-server.com/mmc/p/3ob85kez/.

A replay of the webcast may be accessed from the “News and Events” page in the Investors and Media section of the Company’s website at https://ir.2seventybio.com/ and will be available for 30 days following the event.

About 2seventy bio

Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action – 270 miles per hour – to give the people we serve more time. With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, we’re applying this knowledge to deliver the first FDA-approved CAR T cell therapy for multiple myeloma. We are focused on delivering therapies that are designed with the goal to “think” smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our “why” and keeping our people and culture top of mind every day.

For more information, visit www.2seventybio.com.

Follow 2seventy bio on social media: X (formerly Twitter) and LinkedIn.

2seventy bio is a trademark of 2seventy bio, Inc.

Investors:

Elizabeth Pingpank Hickin, 860-463-0469

Elizabeth.pingpank@2seventybio.com



Media:

Jenn Snyder, 617-448-0281

Jenn.snyder@2seventybio.com

Source: 2seventy bio, Inc.

2seventy bio, Inc. (TSVT) will announce its Q4 and full year 2023 financial results on Tuesday, March 5, 2024.

The management team of 2seventy bio, Inc. (TSVT) will be presenting at TD Cowen 44th Annual Healthcare Conference on March 6, 2024, and Leerink Partners Global Biopharma Conference on March 13, 2024.

The earnings call for 2seventy bio, Inc. (TSVT) is scheduled for March 5, 2024, at 8:00 a.m. ET.

Investors can access the webcasts via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/.

The replay of the webcast will be available for 30 days following the event on 2seventy bio’s website.
2seventy bio Inc

NASDAQ:TSVT

TSVT Rankings

TSVT Latest News

TSVT Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Cambridge

About TSVT

we are an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. our name, 2seventy bio, is inspired by the maximum speed of translating human thought into action—270 miles per hour, and at 2seventy, we think in the language of time. with a deep understanding of cancer cell metabolism, genomics, and the human body’s immune response to tumor cells, we’re applying this knowledge and expertise to new classes of cellular therapies that are designed to “think” smarter and faster than cancer. it is this mindset that propels us forward because we know that time matters -- every day, every minute, every second -- to people living with cancer